Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

Peter Rost: Clueless Pfizer Executives

Clueless Pfizer Executives


By Peter Rost, M.D.

On Thursday, November 30, Pfizer’s executives conducted a well rehearsed dog-and-pony show over at Pfizer’s research facilities in Groton, CT. All interest was focused on torcetrapib; the most important new drug in Pfizer's pipeline, which boosts good cholesterol.

According to Forbes, Pfizer Chief Executive Jeffrey Kindler told about 250 analysts and investors attending the meeting that torcetrapib was "one of the most important developments in our generation."

Pfizer research president John LaMattina said, "We believe this is the most important new development in cardiovascular medicine in years,"according to the Wall Street Journal.

On Saturday, December 2—two days later—Pfizer said in a statement that it is terminating all clinical tests of torcetrapib and its plans to bring the drug to market. A board of independent experts had reviewed the latest data from a 15,000-patient test on torcetrapib and found that patients on the drug were dying like flies; almost twice as many dead as on the comparator. The company also said it is asking doctors participating in studies of torcetrapib to tell patients to stop taking the drug immediately.

Associated Press concluded, “The news is devastating to Pfizer, which had been counting on the drug to revitalize stagnant sales that have been hurt by numerous patent expirations on key products. It has said it was spending around $800 million to develop torcetrapib.”

Of course, in the drug industry, bad stuff happens. But in this particular case, the whole scientific world had been worried about the fact that torcetrapib raises blood pressure. Not a good thing for a cardiovascular drug. But that didn't stop the Pfizer executives from hyping torcetrapib. Until it turned out that "one of the most important developments in our generation" was really a killer drug—quite literally.

And this is what makes Pfizer‘s CEO Mr. Kindler and Pfizer’s research chief Dr. LaMattina officially the most clueless executives in the drug business.

*************

Peter Rost, M.D., is a former Vice President of Pfizer. He became well known in 2004 when he emerged as the first drug company executive to speak out in favor of reimportation of drugs. He is the author of “The Whistleblower, Confessions of a Healthcare Hitman,” http://the-whistleblower-by-peter-rost.blogspot.com/. He also writes the daily "Dr. Peter Rost blog," http://peterrost.blogspot.com/

© Scoop Media

 
 
 
Top Scoops Headlines

 

Binoy Kampmark: Biden’s Victory: A Eunuch Presidency Beckons

Whatever was set to happen on November 3, President Donald J. Trump would not lose. Falling in that establishment firebreak against democracy known as the Electoral College would not erase, let alone repudiate him. His now victorious opponent, far ... More>>

Reese Ehrlich: Foreign Correspondent: The Challenge For Joe Biden

If he’s smart, the likely President-elect will stop the unpopular endless wars and use the money to help our domestic economy. By Reese Erlich I’m pissed. I’m pissed at Donald Trump for trying to shut down the vote count early and at Republicans More>>

Boris Johnson At Sea: Coronavirus Confusion In The UK

The tide has been turning against UK Prime Minister Boris Johnson. Oafishly, he has managed to convert that tide into a deluge of dissatisfaction assisted by the gravitational pull of singular incompetence. Much of this is due to such errors of ... More>>

The Conversation: Biodiversity: Where The World Is Making Progress – And Where It’s Not

The future of biodiversity hangs in the balance. World leaders are gathering to review international targets and make new pledges for action to stem wildlife declines. Depending on whether you are a glass half-full or half-empty person, you’re likely ... More>>

The Conversation: The Numbers Suggest The Campaign For Cannabis Reform In NZ Will Outlive The Generations That Voted Against It

Like Brexit in the UK, cannabis reform in New Zealand fell into an age gap — given time, a second referendum would probably succeed. More>>

Gordon Campbell: 22 Short Takes On The US Election

Finally, the long night of Donald Trump’s presidency is over. To date, the courts have been given no cause to conclude that the exhaustively lengthy counts of those mountains of mail ballots was anything other than legal. Stacking the US Supreme ... More>>

Gordon Campbell: On How The US Supreme Court Is Undermining American Democracy

If Joe Biden is elected President next week, here comes the bad news. If Biden tries to defend Obamacare, combat climate change (via say, a variant of the Green New Deal) or tries to improve the access of US women to abortion services , he will run afoul ... More>>

The Coronavirus Republic: Three Million Infections And Rising

The United States is famed for doing things, not to scale, but off it. Size is the be-all and end-all, and the coronavirus is now doing its bit to assure that the country remains unrivalled in the charts of infection . In time, other unfortunates may well ... More>>

 
 
 
 
 
 
 
 
 
  • PublicAddress
  • Pundit
  • Kiwiblog